{"version":"1.0","provider_name":"ArisGlobal","provider_url":"https:\/\/www.arisglobal.com","author_name":"Mladen Prenc","author_url":"https:\/\/www.arisglobal.com\/author\/mprencarisglobal-com\/","title":"LifeSphere MultiVigilance (formerly ARISg\/ARISc) - A Pharmacovigilance Database for Chinese Regulatory Compliance","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"h0fw57c0Yg\"><a href=\"https:\/\/www.arisglobal.com\/uncategorized\/whitepaper-lifesphere-safety-multivigilance-pharmacovigilance-database-chinese-regulatory-compliance\/\">LifeSphere MultiVigilance (formerly ARISg\/ARISc) &#8211; A Pharmacovigilance Database for Chinese Regulatory Compliance<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.arisglobal.com\/uncategorized\/whitepaper-lifesphere-safety-multivigilance-pharmacovigilance-database-chinese-regulatory-compliance\/embed\/#?secret=h0fw57c0Yg\" width=\"600\" height=\"338\" title=\"&#8220;LifeSphere MultiVigilance (formerly ARISg\/ARISc) &#8211; A Pharmacovigilance Database for Chinese Regulatory Compliance&#8221; &#8212; ArisGlobal\" data-secret=\"h0fw57c0Yg\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"China is aligning its regulatory environment with that of global standards with an aim to promote innovation, simplify drug development processes and to enhance the efficacy, quality and safety of the drugs approved. Read this whitepaper to learn how LifeSphere Safety MultiVigilance (ARISc), the drug safety software"}